Sort
78,016 grants matching “breast cancer”
Molecular Biology of the Metastatic Phenotype
$466,239Patricia Schriver Steeg · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
PROOF-OF-CONCEPT STUDIES FOR A NOVEL IMMUNOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER AND COMPANION DIAGNOSTIC
$466,234The University Of Queensland · · FY2025 · Defense Health Agency
Single Cell Sampling of Signaling Activity in Triple Negative Breast Cancer
$466,217David S. Lawrence · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Single Cell Sampling of Signaling Activity in Triple Negative Breast Cancer
$466,217David S. Lawrence · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
CDC7 kinase in normal and cancer cells: potential implications for cancer treatment
$466,183Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2020 · CA
CDC7 kinase in normal and cancer cells: potential implications for cancer treatment
$466,183Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Project 1: Breast Cancer
$466,113Rulla M Tamimi · Brigham And Women'S Hospital · P01 · FY2016 · CA
Systematic Error and Confounding: Meta-Analyses of Alcohol and Disease
$466,088Tanya Natalene Chikritzhs · Scientific Analysis Corporation · R01 · FY2013 · AA
Regulation of the nucleolar RNA exosome in cancer
$466,084Mushui Dai · Oregon Health & Science University · R01 · FY2022 · CA
Administrative Core
$466,079Mauro Ferrari · University Of Texas Hlth Sci Ctr Houston · U54 · FY2010 · CA
DEVELOPMENTAL FUNDS
$466,077Paul A Bunn · University Of Colorado Denver · P30 · FY2014 · CA
Bayesian Rule Learning Methods for Disease Prediction and Biomarker Discovery
$466,076Vanathi Gopalakrishnan · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · LM
Development of Natural Product Leads as Anticancer Therapeutics
$466,064John Beutler · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Integrin alpha6beta4 regulation of cancer epigenetics
$466,053Kathleen L O'Connor · University Of Kentucky · R01 · FY2019 · CA
Integrin alpha6beta4 regulation of cancer epigenetics
$466,053Kathleen L O'Connor · University Of Kentucky · R01 · FY2021 · CA
Integrin alpha6beta4 regulation of cancer epigenetics
$466,053Kathleen L O'Connor · University Of Kentucky · R01 · FY2020 · CA
Understanding the Impact of Microscale and Nanoscale Heterogeneity and Resistance
$466,050Joe W. Gray · Oregon Health & Science University · U54 · FY2021 · CA
Role of pharmacogenetics on exemestane metabolism and toxicity
$466,040Philip Lazarus · Washington State University · R01 · FY2015 · CA
PheWAS and GWAS of Telomere Length to Understand Human Disease
$465,937Scott Joseph Hebbring · Marshfield Clinic Research Foundation · R01 · FY2022 · GM
Enhancement of tumor radiation response by ultrasound-driven nanobubble stimulation
$465,906Agata A Exner · Case Western Reserve University · R01 · FY2024 · CA
Deguelin in therapy of triple negative breast cancer
$465,889Rajendra G Mehta · Iit Research Institute · R01 · FY2012 · CA
Infertility and Long-Term Health Outcomes Among Hispanic Women with Mexican Heritage
$465,871Leslie V Farland · University Of Arizona · R01 · FY2025 · HD
Role of pharmacogenetics on exemestane metabolism and toxicity
$465,866Philip Lazarus · Washington State University · R01 · FY2016 · CA
Genomic and Proteomic Biomarkers of Biological Responses to Exposure
$465,849Coral Lamartiniere · University Of Alabama At Birmingham · U01 · FY2008 · ES
Brca1 in development and tumorigenesis
$465,825Chuxia Deng · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK